UnitedHealth Group (NYSE:UNH) Shares Down 15.4% - What's Next?

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report)'s share price traded down 15.4% during trading on Tuesday . The stock traded as low as $320.52 and last traded at $320.50. 22,518,943 shares traded hands during trading, an increase of 366% from the average session volume of 4,827,803 shares. The stock had previously closed at $378.75.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Barclays cut their price target on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a research note on Thursday. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $560.00 to $350.00 in a research report on Wednesday. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday. Truist Financial dropped their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research report on Monday, April 21st. Finally, Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Six analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $508.38.

UnitedHealth Group Stock Performance

The stock has a market capitalization of $238.25 billion, a P/E ratio of 16.96, a P/E/G ratio of 1.37 and a beta of 0.56. The stock has a 50 day moving average of $478.83 and a 200 day moving average of $517.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company earned $6.91 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 3.20%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 35.18%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Waycross Partners LLC lifted its stake in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after acquiring an additional 658 shares during the last quarter. Full Sail Capital LLC lifted its stake in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares during the last quarter. Lmcg Investments LLC lifted its stake in UnitedHealth Group by 11.8% in the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after acquiring an additional 4,022 shares during the last quarter. Seilern Investment Management Ltd acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $153,015,000. Finally, Oregon Pacific Wealth Management LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $424,000. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.